[et_pb_section fb_built=”1″ _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”1px||0px||false|false” custom_margin_tablet=”1px||0px||false|false” custom_margin_phone=”3px||||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” border_width_top=”0.5px” border_color_top=”#505358″ border_width_bottom=”0.5px” border_color_bottom=”#505358″ global_colors_info=”{}”][et_pb_row _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”10px||10px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_button button_url=”@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1In19@” button_text=”Back to News” _builder_version=”4.19.4″ _dynamic_attributes=”button_url” _module_preset=”default” custom_button=”on” button_text_size=”12px” button_text_color=”#000000″ button_bg_color=”#FFFFFF” button_border_width=”0px” button_font=”Avant Regular||||||||” button_icon=”#||divi||400″ button_icon_color=”#89bbe5″ button_icon_placement=”left” button_on_hover=”off” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}” button_text_color__hover_enabled=”on|hover” button_text_color__hover=”#89bbe5″ button_bg_color__hover_enabled=”on|desktop” button_bg_color__hover=”#FFFFFF” button_bg_enable_color__hover=”on”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.19.4″ _module_preset=”default” custom_padding=”80px||80px||false|false” custom_padding_tablet=”80px||80px||false|false” custom_padding_phone=”40px||80px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title title=”off” author=”off” date=”off” comments=”off” featured_image=”off” module_id=”meta-new” _builder_version=”4.19.4″ _module_preset=”default” title_font=”Avant Regular||||||||” title_text_color=”#000000″ title_font_size=”64px” title_line_height=”70px” meta_font=”Calibri Regular||||||||” meta_text_color=”RGBA(255,255,255,0)” meta_font_size=”10px” meta_line_height=”16px” custom_margin=”0px||0px||false|false” custom_padding=”0px||20px||false|false” custom_css_post_meta=”text-transform: uppercase;” global_colors_info=”{}”][\/et_pb_post_title][et_pb_post_title author=”off” date_format=”j \u00b7 M \u00b7 Y” comments=”off” featured_image=”off” _builder_version=”4.19.4″ _module_preset=”default” title_font=”Avant Regular||||||||” title_text_color=”#000000″ title_font_size=”64px” title_line_height=”70px” meta_font=”Avant Regular||||||||” meta_text_color=”#000000″ meta_font_size=”14px” meta_line_height=”24px” custom_margin=”0px||0px||false|false” custom_padding=”0px||16px||false|false” title_font_size_tablet=”” title_font_size_phone=”42px” title_font_size_last_edited=”on|phone” title_line_height_tablet=”” title_line_height_phone=”48px” title_line_height_last_edited=”on|phone” custom_css_post_meta=”text-transform: uppercase;” global_colors_info=”{}”][\/et_pb_post_title][et_pb_text _builder_version=”4.19.5″ _module_preset=”default” text_font=”Avant Regular||||||||” text_text_color=”#000000″ text_font_size=”20px” text_line_height=”24px” link_text_color=”#89BBE5″ custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n
Zurich \/ Berne<\/span> <\/span>\u2013 The Swiss Startup Group AG (SSUG), the DCB Research AG (DCB), a hundred percent daughter company of the Diabetes Center Berne Foundation, and Simon Michel are announcing the launch of the first venture fund dedicated to diabetes technology. The Swiss Diabetes Venture Fund (SDVF) will invest up to CHF 50 million over the next 5 years, with a target portfolio size of 20-30 investments in Switzerland, <\/span>Europe,<\/span> and the USA.<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.19.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.19.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2023\/03\/1648126936671-scaled.jpeg” title_text=”1648126936671″ _builder_version=”4.19.5″ _module_preset=”default” width=”100%” min_height=”100px” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||40px||false|false” custom_padding_tablet=”0px||40px||false|false” custom_padding_phone=”||0px||false|false” global_colors_info=”{}”][et_pb_row column_structure=”3_5,2_5″ module_id=”post-content” _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”3_5″ _builder_version=”4.19.4″ _module_preset=”default” custom_padding=”||0px||false|false” global_colors_info=”{}”][et_pb_text ul_item_indent=”20px” ol_item_indent=”20px” module_id=”post-body” _builder_version=”4.19.5″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”24px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”0px||80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n The Swiss Diabetes Venture Fund (SDVF) will be managed by the investment arm of the SSUG, and benefit from the skills, networks and levers of its three General Partners: Simon Michel who will bring his experience as CEO of the <\/span>Ypsomed<\/span> Group, Derek Brandt as CEO of the DCB with his global reach in the diabetes ecosystem, and Mike Baur, CEO of SSUG, pulling on the resources and experience of SSUGs 6-year track record in building up the largest Swiss venture platform.\u00a0<\/span><\/span>\u00a0<\/span><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.19.5″ _module_preset=”default” text_font=”Avant Regular||on||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”32.5px” link_text_color=”#89BBE5″ background_image=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2022\/12\/Ellipse-24.png” background_size=”contain” background_position=”center_left” custom_margin=”0px||80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”40px||40px||false|false” custom_padding_tablet=”40px||40px||false|false” custom_padding_phone=”0px||0px||false|false” custom_padding_last_edited=”on|phone” text_font_size_tablet=”30px” text_font_size_phone=”24px” text_font_size_last_edited=”on|phone” text_line_height_tablet=”40px” text_line_height_phone=”32px” text_line_height_last_edited=”on|phone” global_colors_info=”{}” custom_margin__hover_enabled=”off|hover” custom_margin__hover=”||48px||false|false”]<\/p>\n \u201cOver the past few <\/span>years,<\/span> a true diabetes-technology-hub has <\/span>emerged<\/span> in the Berne area in Switzerland. This eco-system profits not only from companies like <\/span>Ypsomed<\/span>, but also from strong partnerships with common goals. Teaming up with the world-renowned diabetes clinic UDEM at the <\/span>Insel<\/span> Bern University Hospital, the <\/span>sitem-insel<\/span> translational center that enables faster translation from bench to bed into clinical trials, the Diabetes Center Berne is in an excellent position to scout diabetes technology startups and support them in the translation from bed to market. And for this <\/span>purpose,<\/span> we build the SDVF<\/span>\u201d,<\/span><\/p>\n [\/et_pb_text][et_pb_text ul_item_indent=”20px” ol_item_indent=”20px” module_id=”post-body” _builder_version=”4.19.5″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”24px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”80px||80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n comments Simon Michel on the establishment of the dedicated fund.<\/span>\u00a0<\/span><\/p>\n \u201cWe are proud to officially launch the Swiss Diabetes Venture Fund as the first themed fund in our multi venture fund strategy announced past February,\u201d said Mike Baur, CEO of SSUG. \u201cSwitzerland is a global hub for innovation and Healthtech startups and offers promising opportunities for proactive corporates to boost their innovation agenda through targeted acquisitions. The Swiss Startup Group\u2019s investment experience, channeled through the multi-fund strategy, provides the right platform to execute on highly focused investments delivering high returns. And this is how venture truly becomes a dedicated asset class.\u201d<\/span>\u00a0<\/span><\/p>\n [\/et_pb_text][et_pb_image src=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2023\/03\/dvf-1.jpg” title_text=”dvf” _builder_version=”4.19.5″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.19.5″ _module_preset=”default” text_font_size=”12px” global_colors_info=”{}”]<\/p>\n Simon Michel<\/span> (General Partner <\/span>[<\/span>GP<\/span>]<\/span>)<\/span>, Mike Bau<\/span>r<\/span> (GP)<\/span>,<\/span> Cr<\/span>aig Cooper<\/span> (Investment Director)<\/span>, Derek Brandt<\/span> (GP)<\/span><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.19.5″ _module_preset=”default” text_font=”Avant Regular||on||||||” text_text_color=”#505358″ text_font_size=”23px” text_line_height=”32.5px” link_text_color=”#89BBE5″ background_image=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2022\/12\/Ellipse-24.png” background_size=”contain” background_position=”center_left” custom_margin=”0px||80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”40px||40px||false|false” custom_padding_tablet=”40px||40px||false|false” custom_padding_phone=”0px||0px||false|false” custom_padding_last_edited=”on|phone” text_font_size_tablet=”30px” text_font_size_phone=”24px” text_font_size_last_edited=”on|phone” text_line_height_tablet=”40px” text_line_height_phone=”32px” text_line_height_last_edited=”on|phone” global_colors_info=”{}” custom_margin__hover_enabled=”off|hover” custom_margin__hover=”||48px||false|false”]<\/p>\n \u201cDiabetes is a fast-evolving, global challenge and there is a strong need especially for new diabetes technologies that help people with diabetes in their daily life. With this dedicated fund we want to give those ventures an opportunity to grow their technologies and solutions and help <\/span>closing<\/span> the gaps we <\/span>observe<\/span> in the research<\/span>\u201d<\/span><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.19.5″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n added Derek Brandt, CEO of the DCB.<\/span>\u00a0<\/span><\/p>\n Today, 1 out of 11 adults globally suffers from diabetes. The market for solutions and services for people with diabetes is growing epidemically as the International Diabetes Federation (IDF) states. According to the IDF, the number of people living with diabetes will increase over 50% to 700 million people worldwide until 2045.<\/span><\/i>\u00a0<\/span><\/p>\n [\/et_pb_text][et_pb_divider _builder_version=”4.19.5″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][et_pb_text _builder_version=”4.19.5″ _module_preset=”default” text_font=”Avant Regular||||||||” text_text_color=”#000000″ text_font_size=”42px” text_line_height=”48px” custom_margin=”0px||0px||false|false” custom_padding=”0px||40px||false|false” custom_padding_tablet=”0px||40px||false|false” custom_padding_phone=”||16px||false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_text ul_item_indent=”20px” ol_item_indent=”20px” module_id=”post-body” _builder_version=”4.19.5″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”24px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”0px||80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Founded early 2015 by venture entrepreneurs Mike Baur, Max Meister and\u00a0<\/span>Oliver Walzer, the Swiss Startup Group (SSUG) is today the largest privately financed venture platform in Switzerland. The Group offers its investors advanced venture asset management, and a unique ecosystem and whole lifecycle support to startups. The SSUG has become one of the most active Swiss early-stage investors and has offices in Zurich, Bern, and Lausanne.<\/span>\u00a0<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”2_5″ _builder_version=”4.19.4″ _module_preset=”default” custom_padding=”|||64px|false|false” custom_padding_tablet=”|||0px|false|false” custom_padding_phone=”||40px|0px|false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}” custom_padding__hover_enabled=”off|desktop”][et_pb_image src=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2023\/02\/n0jeygivhyiqgw1hshha.webp” title_text=”n0jeygivhyiqgw1hshha” show_bottom_space=”off” _builder_version=”4.19.5″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||16px||false|false” custom_padding_tablet=”0px||16px||false|false” custom_padding_phone=”||8px||false|false” custom_padding_last_edited=”on|phone” hover_enabled=”0″ global_colors_info=”{}” url=”https:\/\/diabetesfund.vc” sticky_enabled=”0″ url_new_window=”on”][\/et_pb_image][et_pb_text _builder_version=”4.19.4″ _module_preset=”default” text_font=”Avant Regular||||||||” text_text_color=”#000000″ text_font_size=”20px” text_line_height=”26px” custom_margin=”0px||16px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n Links<\/p>\n [\/et_pb_text][et_pb_blurb title=”Swiss Diabetes Venture Fund” url=”https:\/\/www.google.com” url_new_window=”on” use_icon=”on” font_icon=”$||divi||400″ icon_color=”#89bbe5″ icon_placement=”left” image_icon_width=”22px” module_id=”media-blurb” _builder_version=”4.19.5″ _module_preset=”default” header_font=”Calibri Regular||||||||” header_text_color=”#000000″ header_font_size=”14px” header_line_height=”20px” body_font=”Calibri Regular||||||||” body_text_color=”#505358″ body_font_size=”12px” body_line_height=”18px” body_link_text_color=”#89BBE5″ image_icon_custom_margin=”4px|0px|0px|0px|false|false” image_icon_custom_padding=”4px|4px|4px|4px|false|false” custom_margin=”0px||0px||false|false” custom_padding=”28px|16px|28px|16px|false|false” custom_css_blurb_image=”position: absolute;||right: 0px;” custom_css_blurb_title=”padding: 0px;||margin: 0px 0px 0px 0px;” custom_css_blurb_content=”padding: 0px;||margin: 0px 0px 0px -10px;” border_width_all=”0.5px” border_color_all=”#505358″ border_width_bottom=”0px” border_radii_image=”on|100px|100px|100px|100px” border_width_all_image=”1px” border_color_all_image=”#89bbe5″ global_colors_info=”{}” icon_color__hover_enabled=”on|hover” icon_color__hover=”#FFFFFF” image_icon_background_color__hover_enabled=”on|hover” image_icon_background_color__hover=”#89BBE5″]<\/p>\nAbout SSUG<\/h1>\n